Review of transplantation of neural stem/progenitor cells for spinal cord injury

International Journal of Developmental Neuroscience

Volumn 31, Issue 7, 2013, Pages 701-713

  Mothe, Andrea J ^a   Tator, Charles H ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Neural stem cells; Spinal cord injury; Transplantation

Indexed keywords

BRAIN NERVE CELL; CELL FUNCTION; CELL SURVIVAL; EMBRYONIC STEM CELL; EXPERIMENTAL STUDY; HUMAN; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PHASE 1 CLINICAL TRIAL (TOPIC); PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SPECIES DIFFERENCE; SPINAL CORD CELL CULTURE; SPINAL CORD INJURY;

NEURAL STEM CELLS; SPINAL CORD INJURY; TRANSPLANTATION;

ANIMALS; CELL DIFFERENTIATION; HUMANS; NEURAL STEM CELLS; SPINAL CORD INJURIES;

EID: 84887605895     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2013.07.004     Document Type: Review

References (148)

1. Abematsu M., Tsujimura K., Yamano M., Saito M., Kohno K., Kohyama J., Namihira M., Komiya S., Nakashima K. Neurons derived from transplanted neural stem cells restore disrupted neuronal circuitry in a mouse model of spinal cord injury. J. Clin. Invest. 2010, 120:3255-3266.
2. Akesson E., Piao J.H., Samuelsson E.B., Holmberg L., Kjaeldgaard A., Falci S., Sundstrom E., Seiger A. Long-term culture and neuronal survival after intraspinal transplantation of human spinal cord-derived neurospheres. Physiol. Behav. 2007, 92:60-66.
3. Alexanian A.R., Svendsen C.N., Crowe M.J., Kurpad S.N. Transplantation of human glial-restricted neural precursors into injured spinal cord promotes functional and sensory recovery without causing allodynia. Cytotherapy 2011, 13:61-68.
4. Bamber N.I., Li H., Aebischer P., Xu X.M. Fetal spinal cord tissue in mini-guidance channels promotes longitudinal axonal growth after grafting into hemisected adult rat spinal cords. Neural Plast. 1999, 6:103-121.
5. Barami K., Zhao J., Diaz F.G., Lyman W.D. Comparison of neural precursor cell fate in second trimester human brain and spinal cord. Neurol. Res. 2001, 23:260-266.
6. Barker R.A., et al. The long-term safety and efficacy of bilateral transplantation of human fetal striatal tissue in patients with mild to moderate Huntington's disease. J. Neurol. Neurosurg. Psychiatry. 2013, 84:657-665.
7. Barker R.A., Barrett J., Mason S.L., Bjorklund A. Fetal dopaminergic transplantation trials and the future of neural grafting in Parkinson's disease. Lancet Neurol. 2013, 12:84-91.
8. Basso D.M., Beattie M.S., Bresnahan J.C. Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 1996, 139:244-256.
9. Behrmann D.L., Bresnahan J.C., Beattie M.S. Modeling of acute spinal cord injury in the rat: neuroprotection and enhanced recovery with methylprednisolone U-74006F and YM-14673. Exp. Neurol. 1994, 126:61-75.
10. Bonner J.F., Connors T.M., Silverman W.F., Kowalski D.P., Lemay M.A., Fischer I. Grafted neural progenitors integrate and restore synaptic connectivity across the injured spinal cord. J. Neurosci. 2011, 31:4675-4686.
11. Bracken M.B., Shepard M.J., Holford T.R., Leo-Summers L., Aldrich E.F., Fazl M., Fehlings M., Herr D.L., Hitchon P.W., Marshall L.F., Nockels R.P., Pascale V., Perot P.L., Piepmeier J., Sonntag V.K., Wagner F., Wilberger J.E., Winn H.R., Young W. Administration of methylprednisolone for 24 or 48hours or tirilazad mesylate for 48hours in the treatment of acute spinal cord injury results of the third national acute spinal cord injury randomized controlled trial. National Acute Spinal Cord Injury Study. JAMA 1997, 277:1597-1604.
12. Bregman B.S., Reier P.J. Neural tissue transplants rescue axotomized rubrospinal cells from retrograde death. J. Comp. Neurol. 1986, 244:86-95.
13. Brustle O., Jones K.N., Learish R.D., Karram K., Choudhary K., Wiestler O.D., Duncan I.D., McKay R.D. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science 1999, 285:754-756.
14. Bunge R.P. Clinical implications of recent advances in neurotrauma research. The Neurobiology of Central Nervous System Trauma 1994, 329-340. Oxford University Press, New York. S.K. Salzman, A.I. Faden (Eds.).
15. Bunge R.P., Puckett W.R., Becerra J.L., Marcillo A., Quencer R.M. Observations on the pathology of human spinal cord injury: a review and classification of 22 new cases with details from a case of chronic cord compression with extensive focal demyelination. Adv. Neurol. 1993, 75-89. 1993/01/01 Edition.
16. Caldwell M.A., He X., Wilkie N., Pollack S., Marshall G., Wafford K.A., Svendsen C.N. Growth factors regulate the survival and fate of cells derived from human neurospheres. Nat. Biotechnol. 2001, 19:475-479.
17. Cao Q., Xu X.M., Devries W.H., Enzmann G.U., Ping P., Tsoulfas P., Wood P.M., Bunge M.B., Whittemore S.R. Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J. Neurosci. 2005, 25:6947-6957.
18. Carpenter M.K., Inokuma M.S., Denham J., Mujtaba T., Chiu C.P., Rao M.S. Enrichment of neurons and neural precursors from human embryonic stem cells. Exp. Neurol. 2001, 172:383-397.
19. Carpenter M.K., Cui X., Hu Z.Y., Jackson J., Sherman S., Seiger A., Wahlberg L.U. In vitro expansion of a multipotent population of human neural progenitor cells. Exp. Neurol. 1999, 158:265-278.
20. Chen Y., Tang Y., Vogel L.C., Devivo M.J. Causes of spinal cord injury. Top Spinal Cord Inj. Rehabil. 2013, 19:1-8.
21. Chiasson B.J., Tropepe V., Morshead C.M., van der Kooy D. Adult mammalian forebrain ependymal and subependymal cells demonstrate proliferative potential, but only subependymal cells have neural stem cell characteristics. J. Neurosci. 1999, 19:4462-4471.
22. Constantini S., Young W. The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. J. Neurosurg. 1994, 80:97-111.
23. Cummings B.J., Uchida N., Tamaki S.J., Anderson A.J. Human neural stem cell differentiation following transplantation into spinal cord injured mice: association with recovery of locomotor function. Neurol. Res. 2006, 28:474-481.
24. Cummings B.J., Uchida N., Tamaki S.J., Salazar D.L., Hooshmand M., Summers R., Gage F.H., Anderson A.J. Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. PNAS 2005, 102:14069-14074.
25. Cusimano M., Biziato D., Brambilla E., Donega M., Alfaro-Cervello C., Snider S., Salani G., Pucci F., Comi G., Garcia-Verdugo J.M., De Palma M., Martino G., Pluchino S. Transplanted neural stem/precursor cells instruct phagocytes and reduce secondary tissue damage in the injured spinal cord. Brain 2012, 135:447-460.
26. Davies J.E., Proschel C., Zhang N., Noble M., Mayer-Proschel M., Davies S.J. Transplanted astrocytes derived from BMP- or CNTF-treated glial-restricted precursors have opposite effects on recovery and allodynia after spinal cord injury. J. Biol. 2008, 7:24.
27. Davies J.E., Huang C., Proschel C., Noble M., Mayer-Proschel M., Davies S.J. Astrocytes derived from glial-restricted precursors promote spinal cord repair. J Biol. 2006, 5:7.
28. Davies S.J., Shih C.H., Noble M., Mayer-Proschel M., Davies J.E., Proschel C. Transplantation of specific human astrocytes promotes functional recovery after spinal cord injury. PLoS One 2011, 6:e17328.
29. Dromard C., et al. Adult human spinal cord harbors neural precursor cells that generate neurons and glial cells in vitro. J. Neurosci. Res. 2008, 86:1916-1926.
30. Enzmann G.U., Benton R.L., Talbott J.F., Cao Q., Whittemore S.R. Functional considerations of stem cell transplantation therapy for spinal cord repair. J. Neurotrauma. 2006, 23:479-495.
31. Farry, A., Baxter, D., 2010. The Incidence and Prevalence of Spinal Cord Injury in Canada. In: Rick Hanson Institute and Urban Futures Report.
32. Fehlings M.G., Vawda R. Cellular treatments for spinal cord injury: the time is right for clinical trials. Neurotherapeutics 2011, 8:704-720.
33. Fehlings M.G., Sekhon L.H. Acute interventions in spinal cord injury: what do we know, what should we do?. Clin. Neurosurg. 2001, 48:226-242.
34. Ferrari D., Zalfa C., Rota Nodari L., Gelati M., Carlessi L., Delia D., Vescovi A.L., De Filippis L. Differential pathotropism of non-immortalized and immortalized human neural stem cell lines in a focal demyelination model. Cell. Mol. Life Sci. 2011, 69:1193-1210.
35. Freed C.R., Zhou W., Breeze R.E. Dopamine cell transplantation for Parkinson's disease: the importance of controlled clinical trials. Neurotherapeutics 2011, 8:549-561.
36. Fujimoto Y., Abematsu M., Falk A., Tsujimura K., Sanosaka T., Juliandi B., Semi K., Namihira M., Komiya S., Smith A., Nakashima K. Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells. Stem Cells 2012, 30:1163-1173.
37. Furlan J.C., Fehlings M.G. The impact of age on mortality, impairment, and disability among adults with acute traumatic spinal cord injury. J. Neurotrauma. 2009, 26:1707-1717.
38. Gage F.H. Mammalian neural stem cells. Science 2000, 287:1433-1438.
39. Garcia-Altes A., Perez K., Novoa A., Suelves J.M., Bernabeu M., Vidal J., Arrufat V., Santamarina-Rubio E., Ferrando J., Cogollos M., Cantera C.M., Luque J.C. Spinal cord injury and traumatic brain injury: a cost-of-illness study. Neuroepidemiology 2012, 39:103-108.
40. Giovanini M.A., Reier P.J., Eskin T.A., Wirth E., Anderson D.K. Characteristics of human fetal spinal cord grafts in the adult rat spinal cord: influences of lesion and grafting conditions. Exp. Neurol. 1997, 148:523-543.
41. Gonzalez F., Boue S., Izpisua Belmonte J.C. Methods for making induced pluripotent stem cells: reprogramming a la carte. Nat. Rev. Genet. 2011, 12:231-242.
42. Gritti A., Parati E.A., Cova L., Frolichsthal P., Galli R., Wanke E., Faravelli L., Morassutti D.J., Roisen F., Nickel D.D., Vescovi A.L. Multipotential stem cells from the adult mouse brain proliferate and self-renew in response to basic fibroblast growth factor. J. Neurosci. 1996, 16:1091-1100.
43. Guest J., Benavides F., Padgett K., Mendez E., Tovar D. Technical aspects of spinal cord injections for cell transplantation. Clinical and translational considerations. Brain Res. Bull. 2011, 84:267-279.
44. Guo X., Zahir T., Mothe A., Shoichet M.S., Morshead C.M., Katayama Y., Tator C.H. The effect of growth factors and soluble nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord. Cell Transplant. 2012, 21:1177-1197.
45. Gupta N., Henry R.G., Strober J., Kang S.M., Lim D.A., Bucci M., Caverzasi E., Gaetano L., Mandelli M.L., Ryan T., Perry R., Farrell J., Jeremy R.J., Ulman M., Huhn S.L., Barkovich A.J., Rowitch D.H. Neural stem cell engraftment and myelination in the human brain. Sci. Transl. Med. 2012, 4. 155ra137.
46. Haas C., Fischer I. Human astrocytes derived from glial restricted progenitors support regeneration of the injured spinal cord. J. Neurotrauma. 2013.
47. Hagg T., Oudega M. Degenerative and spontaneous regenerative processes after spinal cord injury. J. Neurotrauma. 2006, 23:264-280.
48. Hains B.C., Johnson K.M., Eaton M.J., Willis W.D., Hulsebosch C.E. Serotonergic neural precursor cell grafts attenuate bilateral hyperexcitability of dorsal horn neurons after spinal hemisection in rat. Neuroscience 2003, 116:1097-1110.
49. Hains B.C., Yucra J.A., Eaton M.J., Hulsebosch C.E. Intralesion transplantation of serotonergic precursors enhances locomotor recovery but has no effect on development of chronic central pain following hemisection injury in rats. Neurosci. Lett. 2002, 324:222-226.
50. Hains B.C., Fullwood S.D., Eaton M.J., Hulsebosch C.E. Subdural engraftment of serotonergic neurons following spinal hemisection restores spinal serotonin downregulates serotonin transporter, and increases BDNF tissue content in rat. Brain Res. 2001, 913:35-46.
51. Hains B.C., Johnson K.M., McAdoo D.J., Eaton M.J., Hulsebosch C.E. Engraftment of serotonergic precursors enhances locomotor function and attenuates chronic central pain behavior following spinal hemisection injury in the rat. Exp. Neurol. 2001, 171:361-378.
52. Hawryluk G.W., Mothe A., Wang J., Wang S., Tator C., Fehlings M.G. An in vivo characterization of trophic factor production following neural precursor cell or bone marrow stromal cell transplantation for spinal cord injury. Stem Cells Dev. 2012, 21:2222-2238.
53. Hawryluk G.W., Mothe A.J., Chamankhah M., Wang J., Tator C., Fehlings M.G. In vitro characterization of trophic factor expression in neural precursor cells. Stem Cells Dev. 2012, 21:432-447.
54. Hayashi K., Hashimoto M., Koda M., Naito A.T., Murata A., Okawa A., Takahashi K., Yamazaki M. Increase of sensitivity to mechanical stimulus after transplantation of murine induced pluripotent stem cell-derived astrocytes in a rat spinal cord injury model. J. Neurosurg. Spine. 2011, 15:582-593.
55. Herrera J., Yang H., Zhang S.C., Proschel C., Tresco P., Duncan I.D., Luskin M., Mayer-Proschel M. Embryonic-derived glial-restricted precursor cells (GRP cells) can differentiate into astrocytes and oligodendrocytes in vivo. Exp. Neurol. 2001, 171:11-21.
56. Hofstetter C.P., Holmstrom N.A., Lilja J.A., Schweinhardt P., Hao J., Spenger C., Wiesenfeld-Hallin Z., Kurpad S.N., Frisen J., Olson L. Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat. Neurosci. 2005, 8:346-353.
57. Hooshmand M.J., Sontag C.J., Uchida N., Tamaki S., Anderson A.J., Cummings B.J. Analysis of host-mediated repair mechanisms after human CNS-stem cell transplantation for spinal cord injury: correlation of engraftment with recovery. PLoS One 2009, 4:e5871.
58. Hu B.Y., Weick J.P., Yu J., Ma L.X., Zhang X.Q., Thomson J.A., Zhang S.C. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. PNAS 2010, 107:4335-4340.
59. Hulsebosch C.E. From discovery to clinical trials: treatment strategies for central neuropathic pain after spinal cord injury. Curr. Pharm. Des. 2005, 11:1411-1420.
60. Hulsebosch C.E. Recent advances in pathophysiology and treatment of spinal cord injury. Adv. Physiol. Educ. 2002, 26:238-255.
61. Hurlbert R.J., Hamilton M.G. Methylprednisolone for acute spinal cord injury: 5-year practice reversal. Can. J. Neurol. Sci. 2008, 35:41-45.
62. Ikegami T., Nakamura M., Yamane J., Katoh H., Okada S., Iwanami A., Watanabe K., Ishii K., Kato F., Fujita H., Takahashi T., Okano H.J., Toyama Y., Okano H. Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43-positive fibers after rat spinal cord injury. Eur. J. Neurosci. 2005, 22:3036-3046.
63. Imitola J., Raddassi K., Park K.I., Mueller F.J., Nieto M., Teng Y.D., Frenkel D., Li J., Sidman R.L., Walsh C.A., Snyder E.Y., Khoury S.J. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway. PNAS 2004, 101:18117-18122.
64. Iwanami A., Kaneko S., Nakamura M., Kanemura Y., Mori H., Kobayashi S., Yamasaki M., Momoshima S., Ishii H., Ando K., Tanioka Y., Tamaoki N., Nomura T., Toyama Y., Okano H. Transplantation of human neural stem cells for spinal cord injury in primates. J. Neurosci. Res. 2005, 80:182-190.
65. Jin Y., Neuhuber B., Singh A., Bouyer J., Lepore A., Bonner J., Himes T., Campanelli J.T., Fischer I. Transplantation of human glial restricted progenitors and derived astrocytes into a contusion model of spinal cord injury. J. Neurotrauma. 2011, 28:579-594.
66. Johnson P.J., Tatara A., McCreedy D.A., Shiu A., Sakiyama-Elbert S.E. Tissue-engineered fibrin scaffolds containing neural progenitors enhance functional recovery in a subacute model of SCI. Soft Matter 2010, 6:5127-5137.
67. Karimi-Abdolrezaee S., Eftekharpour E., Wang J., Schut D., Fehlings M.G. Synergistic effects of transplanted adult neural stem/progenitor cells, chondroitinase, and growth factors promote functional repair and plasticity of the chronically injured spinal cord. J. Neurosci. 2010, 30:1657-1676.
68. Karimi-Abdolrezaee S., Eftekharpour E., Wang J., Morshead C.M., Fehlings M.G. Delayed transplantation of adult neural precursor cells promotes remyelination and functional neurological recovery after spinal cord injury. J. Neurosci. 2006, 26:3377-3389.
69. Keirstead H.S., Nistor G., Bernal G., Totoiu M., Cloutier F., Sharp K., Steward O. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J. Neurosci. 2005, 25:4694-4705.
70. Kim H., Zahir T., Tator C.H., Shoichet M.S. Effects of dibutyryl cyclic-AMP on survival and neuronal differentiation of neural stem/progenitor cells transplanted into spinal cord injured rats. PLoS One 2011, 6:e21744.
71. Kukekov V.G., Laywell E.D., Suslov O., Davies K., Scheffler B., Thomas L.B., O'Brien T.F., Kusakabe M., Steindler D.A. Multipotent stem/progenitor cells with similar properties arise from two neurogenic regions of adult human brain. Exp. Neurol. 1999, 156:333-344.
72. Kulbatski I., Mothe A.J., Keating A., Hakamata Y., Kobayashi E., Tator C.H. Oligodendrocytes and radial glia derived from adult rat spinal cord progenitors: morphological and immunocytochemical characterization. J. Histochem. Cytochem. 2007.
73. Kumagai G., Okada Y., Yamane J., Nagoshi N., Kitamura K., Mukaino M., Tsuji O., Fujiyoshi K., Katoh H., Okada S., Shibata S., Matsuzaki Y., Toh S., Toyama Y., Nakamura M., Okano H. Roles of ES cell-derived gliogenic neural stem/progenitor cells in functional recovery after spinal cord injury. PLoS One 2009, 4:e7706.
74. Kwon B.K., Okon E., Hillyer J., Mann C., Baptiste D., Weaver L.C., Fehlings M.G., Tetzlaff W. A systematic review of non-invasive pharmacologic neuroprotective treatments for acute spinal cord injury. J. Neurotrauma. 2011, 28:1545-1588.
75. Lepore A.C., Fischer I. Lineage-restricted neural precursors survive migrate, and differentiate following transplantation into the injured adult spinal cord. Exp. Neurol. 2005, 194:230-242.
76. Lindvall O. Developing dopaminergic cell therapy for Parkinson's disease-give up or move forward?. Mov. Disord. 2013, 28:268-273.
77. Lu P., Jones L.L., Snyder E.Y., Tuszynski M.H. Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp. Neurol. 2003, 181:115-129.
78. Lujan E., Chanda S., Ahlenius H., Sudhof T.C., Wernig M. Direct conversion of mouse fibroblasts to self-renewing tripotent neural precursor cells. PNAS 2012, 109:2527-2532.
79. Macias M.Y., Syring M.B., Pizzi M.A., Crowe M.J., Alexanian A.R., Kurpad S.N. Pain with no gain: allodynia following neural stem cell transplantation in spinal cord injury. Exp. Neurol. 2006, 201:335-348.
80. Martens D.J., Seaberg R.M., van der Kooy D. In vivo infusions of exogenous growth factors into the fourth ventricle of the adult mouse brain increase the proliferation of neural progenitors around the fourth ventricle and the central canal of the spinal cord. Eur. J. Neurosci. 2002, 16:1045-1057.
81. McDonald J.W., Liu X.Z., Qu Y., Liu S., Mickey S.K., Turetsky D., Gottlieb D.I., Choi D.W. Transplanted embryonic stem cells survive differentiate and promote recovery in injured rat spinal cord. Nat. Med. 1999, 5:1410-1412.
82. McKay R. Stem cells in the central nervous system. Science 1997, 276:66-71.
83. Mitsui T., Shumsky J.S., Lepore A.C., Murray M., Fischer I. Transplantation of neuronal and glial restricted precursors into contused spinal cord improves bladder and motor functions, decreases thermal hypersensitivity, and modifies intraspinal circuitry. J. Neurosci. 2005, 25:9624-9636.
84. Miura K., Okada Y., Aoi T., Okada A., Takahashi K., Okita K., Nakagawa M., Koyanagi M., Tanabe K., Ohnuki M., Ogawa D., Ikeda E., Okano H., Yamanaka S. Variation in the safety of induced pluripotent stem cell lines. Nat. Biotechnol. 2009, 27:743-745.
85. Moreno-Manzano V., Rodriguez-Jimenez F.J., Garcia-Rosello M., Lainez S., Erceg S., Calvo M.T., Ronaghi M., Lloret M., Planells-Cases R., Sanchez-Puelles J.M., Stojkovic M. Activated spinal cord ependymal stem cells rescue neurological function. Stem Cells 2009, 27:733-743.
86. Morshead C.M., Reynolds B.A., Craig C.G., McBurney M.W., Staines W.A., Morassutti D., Weiss S., van der Kooy D. Neural stem cells in the adult mammalian forebrain: a relatively quiescent subpopulation of subependymal cells. Neuron 1994, 13:1071-1082.
87. Mothe A.J., Tam R.Y., Zahir T., Tator C.H., Shoichet M.S. Repair of the injured spinal cord by transplantation of neural stem cells in a hyaluronan-based hydrogel. Biomaterials 2013, 34:3775-3783.
88. Mothe A.J., Tator C.H. Advances in stem cell therapy for spinal cord injury. J. Clin. Invest. 2012, 122:3824-3834.
89. Mothe A.J., Zahir T., Santaguida C., Cook D., Tator C.H. Neural stem/progenitor cells from the adult human spinal cord are multipotent and self-renewing and differentiate after transplantation. PLoS One 2011, 6:e27079.
90. Mothe A.J., Bozkurt G., Catapano J., Zabojova J., Wang X., Keating A., Tator C.H. Intrathecal transplantation of stem cells by lumbar puncture for thoracic spinal cord injury in the rat. Spinal Cord 2011, 49:967-973.
91. Mothe A.J., Tator C.H. Transplanted neural stem/progenitor cells generate myelinating oligodendrocytes and Schwann cells in spinal cord demyelination and dysmyelination. Exp. Neurol. 2008, 213:176-190.
92. Mothe A.J., Kulbatski I., Parr A., Mohareb M., Tator C.H. Adult spinal cord stem/progenitor cells transplanted as neurospheres preferentially differentiate into oligodendrocytes in the adult rat spinal cord. Cell Transplant. 2008, 17:735-751.
93. Nistor G.I., Totoiu M.O., Haque N., Carpenter M.K., Keirstead H.S. Human embryonic stem cells differentiate into oligodendrocytes in high purity and myelinate after spinal cord transplantation. Glia 2005, 49:385-396.
94. Nori S., Okada Y., Yasuda A., Tsuji O., Takahashi Y., Kobayashi Y., Fujiyoshi K., Koike M., Uchiyama Y., Ikeda E., Toyama Y., Yamanaka S., Nakamura M., Okano H. Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. PNAS 2011, 108:16825-16830.
95. Nunes M.C., Roy N.S., Keyoung H.M., Goodman R.R., McKhann G., 2nd, Jiang L., Kang J., Nedergaard M., Goldman S.A. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat. Med. 2003, 9:439-447.
96. Ogawa Y., Sawamoto K., Miyata T., Miyao S., Watanabe M., Nakamura M., Bregman B.S., Koike M., Uchiyama Y., Toyama Y., Okano H. Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. J. Neurosci. Res. 2002, 69:925-933.
97. Okada S., Ishii K., Yamane J., Iwanami A., Ikegami T., Katoh H., Iwamoto Y., Nakamura M., Miyoshi H., Okano H.J., Contag C.H., Toyama Y., Okano H. In vivo imaging of engrafted neural stem cells: its application in evaluating the optimal timing of transplantation for spinal cord injury. FASEB J. 2005, 19:1839-1841.
98. One Degree of Separation, 2010: Paralysis and SCI in the United States. In: Christopher and Dana Reeve Foundation.
99. Ostenfeld T., Joly E., Tai Y.T., Peters A., Caldwell M., Jauniaux E., Svendsen C.N. Regional specification of rodent and human neurospheres. Brain Res. Dev. Brain Res. 2002, 134:43-55.
100. Palmer T.D., Schwartz P.H., Taupin P., Kaspar B., Stein S.A., Gage F.H. Cell culture: progenitor cells from human brain after death. Nature 2001, 411:42-43.
101. Palmer T.D., Takahashi J., Gage F.H. The adult rat hippocampus contains primordial neural stem cells. Mol. Cell Neurosci. 1997, 8:389-404.
102. Parr A.M., Kulbatski I., Zahir T., Wang X., Yue C., Keating A., Tator C.H. Transplanted adult spinal cord-derived neural stem/progenitor cells promote early functional recovery after rat spinal cord injury. Neuroscience 2008, 155:760-770.
103. Parr A.M., Kulbatski I., Tator C.H. Transplantation of adult rat spinal cord stem/progenitor cells for spinal cord injury. J. Neurotrauma. 2007, 24:835-845.
104. Pearl J.I., Kean L.S., Davis M.M., Wu J.C. Pluripotent stem cells: immune to the immune system?. Sci. Transl. Med. 2012, 4. 164ps125.
105. Pfeifer K., Vroemen M., Blesch A., Weidner N. Adult neural progenitor cells provide a permissive guiding substrate for corticospinal axon growth following spinal cord injury. Eur. J. Neurosci. 2004, 20:1695-1704.
106. Piao J.H., Odeberg J., Samuelsson E.B., Kjaeldgaard A., Falci S., Seiger A., Sundstrom E., Akesson E. Cellular composition of long-term human spinal cord- and forebrain-derived neurosphere cultures. J. Neurosci. Res. 2006, 84:471-482.
107. Pickett G.E., Campos-Benitez M., Keller J.L., Duggal N. Epidemiology of traumatic spinal cord injury in Canada. Spine (Phila, Pa, 1976) 2006, 31:799-805.
108. Quinn S.M., Walters W.M., Vescovi A.L., Whittemore S.R. Lineage restriction of neuroepithelial precursor cells from fetal human spinal cord. J. Neurosci. Res. 1999, 57:590-602.
109. Reubinoff B.E., Itsykson P., Turetsky T., Pera M.F., Reinhartz E., Itzik A., Ben-Hur T. Neural progenitors from human embryonic stem cells. Nat. Biotechnol. 2001, 19:1134-1140.
110. Reynolds B.A., Weiss S. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 1992, 255:1707-1710.
111. Riley J., Federici T., Polak M., Kelly C., Glass J., Raore B., Taub J., Kesner V., Feldman E.L., Boulis N.M. Intraspinal stem cell transplantation in amyotrophic lateral sclerosis: a phase I safety trial, technical note, and lumbar safety outcomes. Neurosurgery 2012, 71:405-416. discussion 416.
112. Roy N.S., Nakano T., Keyoung H.M., Windrem M., Rashbaum W.K., Alonso M.L., Kang J., Peng W., Carpenter M.K., Lin J., Nedergaard M., Goldman S.A. Telomerase immortalization of neuronally restricted progenitor cells derived from the human fetal spinal cord. Nat. Biotechnol. 2004, 22:297-305.
113. Sahni V., Kessler J.A. Stem cell therapies for spinal cord injury. Nat. Rev. Neurol. 2010, 6:363-372.
114. Salazar D.L., Uchida N., Hamers F.P., Cummings B.J., Anderson A.J. Human neural stem cells differentiate and promote locomotor recovery in an early chronic spinal cord injury NOD-scid mouse model. PLoS One 2010, 5:e12272.
115. Salewski R.P., Buttigieg J., Mitchell R.A., van der Kooy D., Nagy A., Fehlings M.G. The generation of definitive neural stem cells from piggybac transposon-induced pluripotent stem cells can be enhanced by induction of the NOTCH signaling pathway. Stem Cells Dev. 2013, 22(3):383-396.
116. Schwartz P.H., Bryant P.J., Fuja T.J., Su H., O'Dowd D.K., Klassen H. Isolation and characterization of neural progenitor cells from post-mortem human cortex. J. Neurosci. Res. 2003, 74:838-851.
117. Sekhon L.H., Fehlings M.G. Epidemiology demographics, and pathophysiology of acute spinal cord injury. Spine (Phila, Pa, 1976) 2001, 26:S2-S12.
118. Selden N.R., Al-Uzri A., Huhn S.L., Koch T.K., Sikora D.M., Nguyen-Driver M.D., Guillaume D.J., Koh J.L., Gultekin S.H., Anderson J.C., Vogel H., Sutcliffe T.L., Jacobs Y., Steiner R.D. Central nervous system stem cell transplantation for children with neuronal ceroid lipofuscinosis. J. Neurosurg. Pediatr. 2013, 11:643-652.
119. Sharp J., Frame J., Siegenthaler M., Nistor G., Keirstead H.S. Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants improve recovery after cervical spinal cord injury. Stem Cells 2010, 28:152-163.
120. Snyder E.Y., Teng Y.D. Stem cells and spinal cord repair. N. Engl. J. Med. 2012, 366:1940-1942.
121. Suslov O.N., Kukekov V.G., Ignatova T.N., Steindler D.A. Neural stem cell heterogeneity demonstrated by molecular phenotyping of clonal neurospheres. PNAS 2002, 99:14506-14511.
122. Svendsen C.N., ter Borg M.G., Armstrong R.J., Rosser A.E., Chandran S., Ostenfeld T., Caldwell M.A. A new method for the rapid and long term growth of human neural precursor cells. J. Neurosci. Methods 1998, 85:141-152.
123. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
124. Tarasenko Y.I., Gao J., Nie L., Johnson K.M., Grady J.J., Hulsebosch C.E., McAdoo D.J., Wu P. Human fetal neural stem cells grafted into contusion-injured rat spinal cords improve behavior. J. Neurosci. Res. 2007, 85:47-57.
125. Tator C., Poon P. Acute clip impact-compression model. Animal Models of Acute Neurological Injuries 2009, 449-460. Humana Press, New York. J. Chen, Z.C. Xu, X.-M. Xu, J.H. Zhang (Eds.).
126. Tator C.H., Hashimoto R., Raich A., Norvell D., Fehlings M.G., Harrop J.S., Guest J., Aarabi B., Grossman R.G. Translational potential of preclinical trials of neuroprotection through pharmacotherapy for spinal cord injury. J. Neurosurg. Spine. 2012, 17:157-229.
127. Tator C.H. Epidemiology and general characteristics of the spinal cord injury patient. Neurosurgical Topics Contemporary Management of Spinal Cord Injury 1995, 9-13. Thieme, Park Ridge, IL. E.C. Benzel (Ed.).
128. Teng Y.D., Lavik E.B., Qu X., Park K.I., Ourednik J., Zurakowski D., Langer R., Snyder E.Y. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. PNAS 2002, 99:3024-3029.
129. Tetzlaff W., Okon E.B., Karimi-Abdolrezaee S., Hill C.E., Sparling J.S., Plemel J.R., Plunet W.T., Tsai E.C., Baptiste D., Smithson L.J., Kawaja M.D., Fehlings M.G., Kwon B.K. A systematic review of cellular transplantation therapies for spinal cord injury. J. Neurotrauma. 2011, 28:1611-1682.
130. Thomas K.E., Moon L.D. Will stem cell therapies be safe and effective for treating spinal cord injuries?. Br. Med. Bull. 2011, 98:127-142.
131. Tropepe V., Hitoshi S., Sirard C., Mak T.W., Rossant J., van der Kooy D. Direct neural fate specification from embryonic stem cells: a primitive mammalian neural stem cell stage acquired through a default mechanism. Neuron 2001, 30:65-78.
132. Tsuji O., et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. PNAS 2010, 107:12704-12709.
133. Vescovi A.L., Parati E.A., Gritti A., Poulin P., Ferrario M., Wanke E., Frolichsthal-Schoeller P., Cova L., Arcellana-Panlilio M., Colombo A., Galli R. Isolation and cloning of multipotential stem cells from the embryonic human CNS and establishment of transplantable human neural stem cell lines by epigenetic stimulation. Exp. Neurol. 1999, 156:71-83.
134. Vroemen M., Aigner L., Winkler J., Weidner N. Adult neural progenitor cell grafts survive after acute spinal cord injury and integrate along axonal pathways. Eur. J. Neurosci. 2003, 18:743-751.
135. Wada T., Honda M., Minami I., Tooi N., Amagai Y., Nakatsuji N., Aiba K. Highly efficient differentiation and enrichment of spinal motor neurons derived from human and monkey embryonic stem cells. PLoS One 2009, 4:e6722.
136. Weiss S., Dunne C., Hewson J., Wohl C., Wheatley M., Peterson A.C., Reynolds B.A. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J. Neurosci. 1996, 16:7599-7609.
137. Wichterle H., Lieberam I., Porter J.A., Jessell T.M. Directed differentiation of embryonic stem cells into motor neurons. Cell 2002, 110:385-397.
138. Wright K.T., El Masri W., Osman A., Chowdhury J., Johnson W.E. Bone marrow for the treatment of spinal cord injury: mechanisms and clinical application. Stem Cells 2010.
139. Yamane J., Nakamura M., Iwanami A., Sakaguchi M., Katoh H., Yamada M., Momoshima S., Miyao S., Ishii K., Tamaoki N., Nomura T., Okano H.J., Kanemura Y., Toyama Y., Okano H. Transplantation of galectin-1-expressing human neural stem cells into the injured spinal cord of adult common marmosets. J. Neurosci. Res. 2010, 88:1394-1405.
140. Yan J., Xu L., Welsh A.M., Hatfield G., Hazel T., Johe K., Koliatsos V.E. Extensive neuronal differentiation of human neural stem cell grafts in adult rat spinal cord. PLoS Med. 2007, 4:e39.
141. Yan J., Welsh A.M., Bora S.H., Snyder E.Y., Koliatsos V.E. Differentiation and tropic/trophic effects of exogenous neural precursors in the adult spinal cord. J. Comp. Neurol. 2004, 480:101-114.
142. Yasuda A., Tsuji O., Shibata S., Nori S., Takano M., Kobayashi Y., Takahashi Y., Fujiyoshi K., Hara C.M., Miyawaki A., Okano H.J., Toyama Y., Nakamura M., Okano H. Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord. Stem Cells 2011, 29:1983-1994.
143. Zhang S.C., Wernig M., Duncan I.D., Brustle O., Thomson J.A. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat. Biotechnol. 2001, 19:1129-1133.
144. Zhang S.C., Ge B., Duncan I.D. Adult brain retains the potential to generate oligodendroglial progenitors with extensive myelination capacity. PNAS 1999, 96:4089-4094.
145. Zhang S.C., Lundberg C., Lipsitz D., O'Connor L.T., Duncan I.D. Generation of oligodendroglial progenitors from neural stem cells. J. Neurocytol. 1998, 27:475-489.
146. Zhao T., Zhang Z.N., Rong Z., Xu Y. Immunogenicity of induced pluripotent stem cells. Nature 2011, 474:212-215.
147. Zhukareva V., Obrocka M., Houle J.D., Fischer I., Neuhuber B. Secretion profile of human bone marrow stromal cells: donor variability and response to inflammatory stimuli. Cytokine 2010, 50:317-321.
148. Ziv Y., Avidan H., Pluchino S., Martino G., Schwartz M. Synergy between immune cells and adult neural stem/progenitor cells promotes functional recovery from spinal cord injury. PNAS 2006, 103.